BAY-2304058

N/A

Report date: 2025/11/07 11:34:20

Base Information

Drug NameBAY-2304058

Drug Alias NameBAY-2304058

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Nuclides > Thorium > 227ThRadiation-emitting products > Radioactive therapeutic agent +[4]

Mechanisms of ActionFibroblast growth factor receptor 2 antagonists

TargetsFibroblast growth factor receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Develop Information

Active CompaniesBayer AG

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A